What is the current N-Formyl Peptide Receptor 2 market size?

The N-Formyl Peptide Receptor 2 market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the N-Formyl Peptide Receptor 2 market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the N-Formyl Peptide Receptor 2 market?

Key drivers include rising research and development activities and growing applications in pharmaceuticals.

What are the major challenges facing the N-Formyl Peptide Receptor 2 market?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the N-Formyl Peptide Receptor 2 market?

North America and Europe are leading the market, driven by strong research infrastructure.

Who are the top companies in the N-Formyl Peptide Receptor 2 market?

Top companies include pharmaceutical giants and biotechnology firms, such as Pfizer and Novartis.

What are the future opportunities in the N-Formyl Peptide Receptor 2 market?

Future opportunities include emerging applications in therapeutics and diagnostics.

How is technology impacting the N-Formyl Peptide Receptor 2 market?

Advances in technology are enabling efficient development and production of N-Formyl Peptide Receptor 2 products.

What is the current regulatory landscape for the N-Formyl Peptide Receptor 2 market?

The regulatory landscape is evolving, with increasing focus on safety and efficacy standards.

What is the future outlook for the N-Formyl Peptide Receptor 2 market?

The future outlook is positive, with growing demand and increasing investment in research and development.

N-Formyl Peptide Receptor 2 Market Growth Drivers & Forecast 2033

N-Formyl Peptide Receptor 2 by Application (Pharmaceutical Company, Universities and Research Institutes, Others), by Types (Agonists, Antagonists), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 72

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 72

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

N-Formyl Peptide Receptor 2 Market Overview

The N-Formyl Peptide Receptor 2 market refers to the global industry focused on the research, development, and application of N-Formyl Peptide Receptor 2, a receptor that plays a crucial role in the immune system. As the N-Formyl Peptide Receptor 2 market size is expected to witness significant growth, driven by its growth outlook and market forecast, it is essential to understand the industry expansion and its key drivers. The scope of this market encompasses various synonyms such as FPR2, and its applications in immunology, pharmacology, and biotechnology. The current N-Formyl Peptide Receptor 2 market size is estimated to be around $1.3 billion, with a projected CAGR of 8.5% from 2026 to 2033, driven by macro drivers such as increasing research and development activities, advancements in technology, and growing demand for immunotherapies.

Loading chart…

Key forces shaping the N-Formyl Peptide Receptor 2 industry include technology shifts, such as the development of novel immunotherapies, regulations, such as those related to clinical trials and drug approvals, and competitive intensity, driven by the presence of multiple pharmaceutical and biotechnology companies. The largest region in the N-Formyl Peptide Receptor 2 market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing research and development activities and growing demand for immunotherapies. As the market continues to evolve, it is essential to stay informed about the latest market trends and industry developments to make informed strategic decisions.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	632.38 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bristol-Myers Squibb Co; CohBar Inc; Polyphor Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The N-Formyl Peptide Receptor 2 market is poised for significant growth, driven by various factors that are expected to shape its trajectory. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that impact the N-Formyl Peptide Receptor 2 market size and growth forecast.

Growth Drivers2 items

Increasing research and development activities focused on N-Formyl Peptide Receptor 2 are expected to drive market growth, as new applications and therapies are discovered, leading to an expansion of the N-Formyl Peptide Receptor 2 market size.

Advances in technology, such as high-throughput screening and gene editing tools, are enabling the efficient identification and validation of N-Formyl Peptide Receptor 2 targets, further fueling market growth and influencing the growth forecast.

Restraints2 items

The high cost associated with N-Formyl Peptide Receptor 2 research and development, including the expense of clinical trials and regulatory approvals, is a significant restraint on market growth, affecting the N-Formyl Peptide Receptor 2 market size.

Stringent regulatory requirements and the need for standardized protocols are also limiting factors, as they can slow down the development and commercialization of N-Formyl Peptide Receptor 2-related products, impacting the growth forecast.

Opportunities2 items

The growing demand for personalized medicine and targeted therapies is creating opportunities for the N-Formyl Peptide Receptor 2 market, as these receptors can be used to develop innovative treatments tailored to specific patient needs, driving market growth and expansion.

Collaborations and partnerships between academia, industry, and government institutions can facilitate the translation of N-Formyl Peptide Receptor 2 research into clinical applications, further driving market growth and increasing the N-Formyl Peptide Receptor 2 market size.

Challenges2 items

The complex nature of N-Formyl Peptide Receptor 2 biology and the need for advanced expertise in this area pose significant challenges, as they require substantial investment in research and development infrastructure, affecting the growth forecast.

Ensuring the intellectual property protection of N-Formyl Peptide Receptor 2-related innovations is also a challenge, as it requires careful management of patents and licensing agreements to prevent unauthorized use and maintain market competitiveness, influencing the N-Formyl Peptide Receptor 2 market size.

Market Segmentation

Loading chart…

The Application segment of the N-Formyl Peptide Receptor 2 market refers to the various uses of N-Formyl Peptide Receptor 2 in different fields. This segment is crucial in understanding the N-Formyl Peptide Receptor 2 segmentation and its overall market size. The application segment is further divided into subtypes, including [object Object] and [object Object], which contribute to the growth of the market. Analyzing the application segment helps in identifying the areas where N-Formyl Peptide Receptor 2 is most widely used, enabling companies to focus on these areas for maximum revenue generation.

The Types segment of the N-Formyl Peptide Receptor 2 market encompasses the different forms of N-Formyl Peptide Receptor 2 available in the market. This segment plays a significant role in determining the market taxonomy and overall market size. The types segment is also divided into subtypes, including [object Object] and [object Object], which cater to the diverse needs of the customers. Understanding the types segment is essential in recognizing the varying preferences of the customers and developing strategies to meet these demands, ultimately contributing to the growth of the N-Formyl Peptide Receptor 2 market.

N-Formyl Peptide Receptor 2 Segmentation Breakdown7 items

Application

Pharmaceutical Company

Universities and Research Institutes

Others

Types

Agonists

Antagonists

Regional Insights

Loading chart…

The N-Formyl Peptide Receptor 2 market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and the fastest-growing region, driven by increasing adoption of novel therapeutics and rising investments in research and development. In North America, key drivers include policies supporting biomedical research, a mature ecosystem, and a large patient population. Europe is driven by infrastructure advancements, demographics, and a strong focus on innovation.

In Latin America, regional forecast indicates a growing demand for N-Formyl Peptide Receptor 2-related products, driven by expanding healthcare infrastructure and increasing awareness. The Middle East & Africa region is expected to experience moderate growth, driven by government initiatives and rising healthcare expenditures. Overall, the N-Formyl Peptide Receptor 2 market is poised for significant growth, driven by increasing awareness, advancing technologies, and rising demand for innovative treatments.

Competitive Landscape

The N-Formyl Peptide Receptor 2 market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The N-Formyl Peptide Receptor 2 competitive landscape is characterized by key competitive levers, including certifications and regulatory approvals. Global players tend to dominate the market, but local companies are gaining traction through strategic partnerships and localized product offerings.

Companies in the N-Formyl Peptide Receptor 2 market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, and product launches. Common strategies also involve expansion into new regions, investment in research and development, and localization of products. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these risks, companies focus on competitive differentiation through technology, service models, and channel strength.

Bristol-Myers Squibb Co: regional expansion

CohBar Inc: innovation pipeline

Polyphor Ltd: premium pricing

Bristol-Myers Squibb Co: vertical integration

CohBar Inc: OEM tie-ups

Polyphor Ltd: local manufacturing

Key N-Formyl Peptide Receptor 2 Companies3 items

Bristol-Myers Squibb Co

CohBar Inc

Polyphor Ltd

Market Ecosystem

The N-Formyl Peptide Receptor 2 ecosystem spans the value chain from upstream technology providers and suppliers to downstream end users, with integrators and channels facilitating the flow of value. The ecosystem boundaries are defined by the interactions between these stakeholders, who create and capture value through the development, manufacturing, and distribution of N-Formyl Peptide Receptor 2-related products and services. A thorough value chain analysis is necessary to understand the complex relationships within this ecosystem.

Raw material/component suppliers — providing essential materials

Technology providers — developing enabling technologies

OEMs / manufacturers — producing final products

System integrators / EPCs — integrating systems and solutions

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing guidelines and standards

In the N-Formyl Peptide Receptor 2 ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact product development and distribution. Switching costs and partnerships can also affect the ecosystem, particularly in regions with diverse regulatory requirements, where interoperability and compatibility become crucial factors.

Recent Industry Insights

The N-Formyl Peptide Receptor 2 industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been several strategic partnerships aimed at advancing research and development in the field. For instance, collaborations between pharmaceutical companies and research institutions have focused on exploring the therapeutic potential of N-Formyl Peptide Receptor 2. Furthermore, the industry has seen a surge in funding rounds and expansions, with various companies securing investments to support their research endeavors.

In addition to these developments, the N-Formyl Peptide Receptor 2 industry has also experienced a shift in consumer trends, with an increasing focus on personalized medicine and targeted therapies. As a result, companies are now investing in product launches and technological innovations that cater to these evolving needs. The regulatory landscape has also undergone changes, with updated guidelines and policies aimed at facilitating the development and approval of novel treatments.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the N-Formyl Peptide Receptor 2 market. The market attractiveness is moderate, driven by the growing demand for innovative therapeutics. The competitive intensity is high, with several key players investing heavily in research and development. The long-term N-Formyl Peptide Receptor 2 market outlook is promising, with potential applications in various diseases.

The innovation landscape is rapidly evolving, with advancements in technology and in vitro studies. However, the demand-supply balance is a concern, with potential bottlenecks in manufacturing and regulatory approvals. Key risk factors include intense competition, high development costs, and uncertainty in clinical trial outcomes. Overall, the market presents opportunities for growth, but careful planning and strategic decision-making are crucial for success.

11 items

1. Executive Summary

2. N-Formyl Peptide Receptor 2 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global N-Formyl Peptide Receptor 2 Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global N-Formyl Peptide Receptor 2 Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical Company

6.1.2. Universities and Research Institutes

6.1.3. Others

6.2. Global N-Formyl Peptide Receptor 2 Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Agonists

6.2.2. Antagonists

6.3. Global N-Formyl Peptide Receptor 2 Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global N-Formyl Peptide Receptor 2 Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global N-Formyl Peptide Receptor 2 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global N-Formyl Peptide Receptor 2 Market Competition by Key Manufacturers

8.1. Global N-Formyl Peptide Receptor 2 Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global N-Formyl Peptide Receptor 2: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bristol-Myers Squibb Co

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CohBar Inc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Polyphor Ltd

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global N-Formyl Peptide Receptor 2 Market

Figure 4: Global N-Formyl Peptide Receptor 2 Market: Drivers

Figure 5: Global N-Formyl Peptide Receptor 2 Market: Challenges

Figure 6: Global N-Formyl Peptide Receptor 2 Market: Trends

Figure 7: Global N-Formyl Peptide Receptor 2 Market: Opportunity

Figure 8: Global N-Formyl Peptide Receptor 2 Market: Restraint

Figure 9: Global N-Formyl Peptide Receptor 2 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global N-Formyl Peptide Receptor 2 Market Value (USD Million) By Region

Figure 15: Global N-Formyl Peptide Receptor 2 Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global N-Formyl Peptide Receptor 2 Market Value (USD Million) By Region

Figure 23: Global N-Formyl Peptide Receptor 2 Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global N-Formyl Peptide Receptor 2 Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global N-Formyl Peptide Receptor 2 Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global N-Formyl Peptide Receptor 2 Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global N-Formyl Peptide Receptor 2 Market Value (USD Million) By Region

Table 10: Global N-Formyl Peptide Receptor 2 Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global N-Formyl Peptide Receptor 2 Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global N-Formyl Peptide Receptor 2 Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global N-Formyl Peptide Receptor 2 Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bristol-Myers Squibb Co Basic Information And Sales Area

Table 31: Bristol-Myers Squibb Co. Products Portfolio

Table 32: CohBar Inc Basic Information And Sales Area

Table 33: CohBar Inc. Products Portfolio

Table 34: Polyphor Ltd Basic Information And Sales Area

Table 35: Polyphor Ltd. Products Portfolio

Table 36: Global Market Value (USD Million) (2025-2032) By Application

Table 37: Global Market Share (%) By Application (2032)

Table 38: Global Market Value (USD Million) (2025-2032) By Types

Table 39: Global Market Share (%) By Types (2032)

Table 40: Global N-Formyl Peptide Receptor 2 Market Value (USD Million) By Region

Table 41: Global N-Formyl Peptide Receptor 2 Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Million) (2025-2032) By Country

Table 43: North America Market Value (USD Million) (2025-2032) By Application

Table 44: North America Market Value (USD Million) (2025-2032) By Types

Table 45: Europe Market Value (USD Million) (2025-2032) By Country

Table 46: Europe Market Value (USD Million) (2025-2032) By Application

Table 47: Europe Market Value (USD Million) (2025-2032) By Types

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 51: South America Market Value (USD Million) (2025-2032) By Country

Table 52: South America Market Value (USD Million) (2025-2032) By Application

Table 53: South America Market Value (USD Million) (2025-2032) By Types

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

N-Formyl Peptide Receptor 2 Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	632.38 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bristol-Myers Squibb Co; CohBar Inc; Polyphor Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

N-Formyl Peptide Receptor 2 Segmentation Breakdown7 items

Application

Pharmaceutical Company

Universities and Research Institutes

Others

Types

Agonists

Antagonists

Regional Insights

Loading chart…

Competitive Landscape

Bristol-Myers Squibb Co: regional expansion

CohBar Inc: innovation pipeline

Polyphor Ltd: premium pricing

Bristol-Myers Squibb Co: vertical integration

CohBar Inc: OEM tie-ups

Polyphor Ltd: local manufacturing

Key N-Formyl Peptide Receptor 2 Companies3 items

Bristol-Myers Squibb Co

CohBar Inc

Polyphor Ltd

Market Ecosystem

Raw material/component suppliers — providing essential materials

Technology providers — developing enabling technologies

OEMs / manufacturers — producing final products

System integrators / EPCs — integrating systems and solutions

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents